golfyeti - If, if, if, if. If they have a good meeting with the FDA, if they are able to arrange the financing to complete the PIII COVID trial, if they are able to get dosing actually started by the end of October when flue season is cranking up and if APB shows positive early results .75 could be left in the dust. Both Biden and Fauci had relapses after Paxlovid use. PFE is expecting $22 billion in Paxlovid sales this year. If our mouse trap catches more mice than the one currently in use then that market could be ours, for a time anyways. Could be why Eversana has steadfastly stayed with us.

tada